Bioray Biotech Co Stock

Bioray Biotech Co Equity

The The Equity of Bioray Biotech Co (7561.TWO) as of Aug 26, 2026 is 453.01 M TWD. In the previous year, The Equity was 420.73 M TWD — a change of 7.67% (higher).

Equity

453.01 MTWD

YoY

7.67%

Last updated:

In 2026, Bioray Biotech Co's equity was 453.01 M TWD, a 7.67% increase from the 420.73 M TWD equity in the previous year.

The Bioray Biotech Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
372.46 M TWD
Jan 1, 2019
377.85 M TWD
Jan 1, 2020
369.37 M TWD
Jan 1, 2021
363.92 M TWD
Jan 1, 2022
451.47 M TWD
Jan 1, 2023
433.90 M TWD
Jan 1, 2024
420.73 M TWD
Jan 1, 2025
453.01 M TWD
The Bioray Biotech Co Equity history
YEAREquityYoY
453.01 MTWD+7.67%
420.73 MTWD-3.03%
433.90 MTWD-3.89%
451.47 MTWD+24.06%
363.92 MTWD-1.48%
369.37 MTWD-2.24%
377.85 MTWD+1.45%
372.46 MTWD+69.88%
219.26 MTWD—
Access this data via the Eulerpool API
Get Free API Key

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? Bioray Biotech Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Bioray Biotech Co's Equity

Bioray Biotech Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bioray Biotech Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bioray Biotech Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bioray Biotech Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bioray Biotech Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bioray Biotech Co stock

The Equity of Bioray Biotech Co is 453.01 M TWD in 2026.

The Equity of Bioray Biotech Co changed from 420.73 M TWD to 453.01 M TWD, representing a 7.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Bioray Biotech Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Bioray Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bioray Biotech Co